Humacyte Eulerpool Novinky

Humacyte Novinky o akciách

Humacyte sledujú mnohí novinári a investori po celom svete. Najaktuálnejšie správy Humacyte zhromažďujeme práve tu.

• 8. januára ·

  SeekingAlpha
  Humacyte: Expect A Slow Launch, But Vascular Trauma Indication Is Just A Beginning
• 23. decembra ·

  SeekingAlpha
  Humacyte's Symvess Debut: A Milestone With Lingering Concerns (Rating Downgrade)
• 20. decembra ·

  Yahoo
  Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma
• 18. decembra ·

  Yahoo
  Individual investors who have a significant stake must be disappointed along with institutions after Humacyte, Inc.'s (NASDAQ:HUMA) market cap dropped by US$60m
• 14. decembra ·

  SeekingAlpha
  Humacyte: FDA Waiting Game Bleeding Company Dry
• 2. decembra ·

  Yahoo
  Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference
• 22. novembra ·

  Yahoo
  Humacyte to Present Efficacy and Safety Results from V007 Phase 3 AV Access Clinical Trial at the 51st Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITH)
• 21. novembra ·

  Yahoo
  Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and Military Arterial Injuries Published in JAMA Surgery
• 18. novembra ·

  Yahoo
  Humacyte Presents Preclinical Results of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting at American Heart Association’s Scientific Sessions 2024
• 14. novembra ·

  Yahoo
  Humacyte Announces Pricing of $15.0 Million Registered Direct Offering